1000207-52-2 Usage
General Description
Tert-butyl 4-(2-chloro-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-ylamino)piperidine-1-carboxylate is a chemical compound with a complex molecular structure. It consists of a tert-butyl group attached to a 1-carboxylate group, connected to a piperidine ring with a 2-chloro-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-ylamino substituent. tert-butyl 4-(2-chloro-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-ylamino)piperidine-1-carboxylate is a derivative of piperidine and exhibits potentially important pharmacological properties. Its specific mechanism of action and potential applications are not specified in the given name, but the presence of a piperidine ring and a cyclopenta[d]pyrimidin-4-ylamino group suggests potential activity as a pharmaceutical agent. Additional research and testing would be needed to determine its specific properties and uses.
Check Digit Verification of cas no
The CAS Registry Mumber 1000207-52-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,0,2,0 and 7 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1000207-52:
(9*1)+(8*0)+(7*0)+(6*0)+(5*2)+(4*0)+(3*7)+(2*5)+(1*2)=52
52 % 10 = 2
So 1000207-52-2 is a valid CAS Registry Number.
1000207-52-2Relevant articles and documents
Synthesis and evaluation of novel fused pyrimidine derivatives as GPR119 agonists
Fang, Yuanying,Xiong, Lijuan,Hu, Jianguo,Zhang, Shaokun,Xie, Saisai,Tu, Liangxing,Wan, Yang,Jin, Yi,Li, Xiang,Hu, Shaojie,Yang, Zunhua
, p. 103 - 111 (2019)
A novel series of fused pyrimidine derivatives were designed, synthesized and evaluated as GPR119 agonists. Among them, cyclohexene fused compounds (tetrahydroquinazolines) showed greater GPR119 agonistic activities than did dihydrocyclopentapyrimidine and tetrahydropyridopyrimidine scaffolds. Analogues (16, 19, 26, 28, 42) bearing endo-N-Boc-nortropane amine and fluoro-substituted aniline exhibited better EC50 values (0.27–1.2 μM) though they appeared to be partial agonists.